These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2827331

  • 1. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M, Drings P, Kleine W, Mattern J.
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [Abstract] [Full Text] [Related]

  • 2. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
    Volm M, Hahn EW, Mattern J, Müller T, Vogt-Moykopf I, Weber E.
    Cancer Res; 1988 May 15; 48(10):2923-8. PubMed ID: 2834052
    [Abstract] [Full Text] [Related]

  • 3. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
    Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K.
    Cytometry; 1985 Jul 15; 6(4):348-56. PubMed ID: 2990835
    [Abstract] [Full Text] [Related]

  • 4. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
    Isobe H.
    Hokkaido Igaku Zasshi; 1991 Jan 15; 66(1):49-58. PubMed ID: 1848524
    [Abstract] [Full Text] [Related]

  • 5. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
    Yamaoka N, Uchiyama Y, Kimino K, Akamine S, Matsuo S, Tsuji K.
    Nihon Geka Gakkai Zasshi; 1990 Oct 15; 91(10):1608-16. PubMed ID: 2175839
    [Abstract] [Full Text] [Related]

  • 6. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ, Joensuu H, Mäenpää J, Kiilholma P.
    Obstet Gynecol; 1989 Aug 15; 74(2):200-4. PubMed ID: 2748056
    [Abstract] [Full Text] [Related]

  • 7. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M, Brüggemann A, Günther M, Kleine W, Pfleiderer A, Vogt-Schaden M.
    Cancer Res; 1985 Oct 15; 45(10):5180-5. PubMed ID: 4027994
    [Abstract] [Full Text] [Related]

  • 8. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
    Stipa S, Danesi DT, Modini C, Cicconetti F, Mauro F, Schillaci A, Mecozzi A, Nicolanti V, Stipa F, Mancini M.
    Surg Gynecol Obstet; 1993 May 15; 176(5):427-34. PubMed ID: 8386859
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometric analysis of primary lung carcinomas and their lymph node metastases.
    Volm M, Mattern J, Vogt-Schaden M, Wayss K.
    Anticancer Res; 1987 May 15; 7(1):71-6. PubMed ID: 3032072
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C, Bocsi J, Bartha I, Math J, Balazs G.
    Anticancer Res; 2002 May 15; 22(6B):3737-41. PubMed ID: 12552986
    [Abstract] [Full Text] [Related]

  • 11. Correlation of model chromosome number of cultured non-small cell lung carcinomas with DNA index of solid tumor tissue.
    Siegfried JM, Ellison DJ, Resau JH, Miura I, Testa JR.
    Cancer Res; 1991 Jun 15; 51(12):3267-73. PubMed ID: 1645617
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
    Volm M, Kleine W.
    Geburtshilfe Frauenheilkd; 1987 Jul 15; 47(7):456-9. PubMed ID: 3623048
    [Abstract] [Full Text] [Related]

  • 13. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
    Nagai S, Chiba W, Ikeda S, Matsumoto H, Fujimoto T, Ishida H, Wazawa H, Hanawa T, Yamashita N, Yasuda Y, Matsubara Y, Hatakenaka R, Funatsu T.
    Gan To Kagaku Ryoho; 1996 Jun 15; 23 Suppl 2():130-4. PubMed ID: 8678555
    [Abstract] [Full Text] [Related]

  • 14. [Demonstration of independent cellular prognostic factors in squamous cell carcinoma of the lung].
    Volm M, Kayser K, Mattern J.
    Strahlenther Onkol; 1989 Aug 15; 165(8):587-92. PubMed ID: 2772815
    [Abstract] [Full Text] [Related]

  • 15. [Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].
    Yamaoka N, Tagawa Y, Miyashita K, Ayabe H, Kawahara K, Uchiyama Y, Tomita M.
    Nihon Geka Gakkai Zasshi; 1991 May 15; 92(5):598-602. PubMed ID: 1875901
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K, Hayashi Y, Nagao S, Watanabe Y.
    Gan To Kagaku Ryoho; 1995 Jun 15; 22 Suppl 2():164-7. PubMed ID: 7611782
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study.
    Volm M, Mattern J, Müller T, Drings P.
    Anticancer Res; 1988 Jun 15; 8(1):105-12. PubMed ID: 3358625
    [Abstract] [Full Text] [Related]

  • 18. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D.
    Cancer Res; 1984 Sep 15; 44(9):4187-96. PubMed ID: 6744328
    [Abstract] [Full Text] [Related]

  • 19. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
    Jeanfaivre T, Chassevent A, Larra F, Tuchais E.
    Bull Cancer; 1994 Jul 15; 81(7):605-9. PubMed ID: 7742603
    [Abstract] [Full Text] [Related]

  • 20. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ.
    Clin Cancer Res; 1997 Jan 15; 3(1):87-93. PubMed ID: 9815542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.